Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Cochran Jack E — CERAGENIX PHARMACEUTICALS, INC. insider: 2 transactions · InsiderLens

Home / Insiders / Cochran Jack E

Cochran Jack E

Director at CERAGENIX PHARMACEUTICALS, INC. · on record since Oct 28, 2004

Insider trading activity of Cochran Jack E

Transactions on record: 2; since Mar 18, 2005

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 18, 2005

Figures computed from official regulatory filings — methodology.

Companies where Cochran Jack E has traded

CERAGENIX PHARMACEUTICALS, INC.2 tx · Mar 18, 2005

Track record of Cochran Jack E

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Cochran Jack E

Co-insiders of Cochran Jack E

ALLEN RUSSELL LCERAGENIX PHARMACEUTICALS, INC.
Barone Vicki D ECERAGENIX PHARMACEUTICALS, INC.
Bautista Alberto JCERAGENIX PHARMACEUTICALS, INC.
Darnaud MichelCERAGENIX PHARMACEUTICALS, INC.
Elias PeterCERAGENIX PHARMACEUTICALS, INC.
Gastone PhilippeCERAGENIX PHARMACEUTICALS, INC.
GENBERG CARLCERAGENIX PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Hoffman Bray Cheryl ACERAGENIX PHARMACEUTICALS, INC.

JENNINGS FRANK LCERAGENIX PHARMACEUTICALS, INC.

NEUMAN CLIFFORD L ESQCERAGENIX PHARMACEUTICALS, INC.

OSMOTICS CORPCERAGENIX PHARMACEUTICALS, INC.

OVERTURF JOHN R JRCERAGENIX PHARMACEUTICALS, INC.

Porter StevenCERAGENIX PHARMACEUTICALS, INC.

Sperber Jeffrey SCERAGENIX PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
CERAGENIX PHARMACEUTICALS, INC.	Mar 18, 2005	Exercise	10,000	0.50 USD	—	SEC
CERAGENIX PHARMACEUTICALS, INC.	Mar 18, 2005	AwardD	10,000	0.50 USD	—	SEC